Last edition
News about "US generics market"
Renova Pharmaceuticals Launches First 3 US Generics
Renova Pharmaceuticals has launched its first 3 US generic products, marking a major milestone in its transition to a growing commercial presence in the US generics market.
US Generics Market | 11/09/2026 | By News Bureau
Alembic Pharma Receives US FDA Approval for Generic Tretinoin Cream
Alembic Pharmaceuticals has secured final USFDA approval for its generic Tretinoin Cream USP, 0.05 percent, used in the treatment of acne vulgaris, targeting a US market estimated at USD 76 million.
US Generics Market | 16/06/2026 | By News Bureau | 214
Granules Pharmaceuticals Secures US FDA Tentative Approval for gDYANAVEL XR
The tentative approval clears a key regulatory milestone for Granules Pharmaceuticals’ Abbreviated New Drug Application (ANDA), which the US FDA has determined to be eligible for 180-day market exclusivity.
US Generics Market | 09/01/2026 | By News Bureau | 203
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy